Bulletin of the World Health Organization : 1968; Volume 39, Number 2, Year 1968, Pages 219-230: Ecological Considerations in Scrub Typhus 2. Vector Species

By Robert Traub

Book Id: WPLBN0000232945
Format Type: PDF eBook:
File Size: 0.6 MB
Reproduction Date: 2005

Title:	Bulletin of the World Health Organization : 1968; Volume 39, Number 2, Year 1968, Pages 219-230: Ecological Considerations in Scrub Typhus 2. Vector Species
Author:	Robert Traub
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Traub, B. R. (n.d.). Bulletin of the World Health Organization : 1968; Volume 39, Number 2, Year 1968, Pages 219-230. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
There is general agreement that the use of drugs should be rational; that is, that the right drug should be used for the right indication, by the right patient, in the right dose, in the right dosage form, for the right period of time and at a reasonable cost. The rational use of drugs is one of the aims of WHO and ways of achieving it are specified in various resolutions passed by the World Health Assembly. Drug utilieation research is an importadt part of the activities necessary to improve the use of drugs. Without a clear knowledge of what is being consumed, by whom, at whose instigation, in which doses and at what cost, nobody can reliably identify problems and set priorities in the pharmaceuticals field, or measure the effect of regulatory or educational activities intended to change current practice . The first meeting of a group of European scientists, later known as the WHO Drug Utilization Research Group (DURG), was convened in Norway in 1969. In those days, drug utilization data were not available to research workers in most places, and only,a small number of countries were represented at the meeting. Since then drug utilization research has developed rapidly, and the number of countries and research workers interested in this field has steadily grown . Meetings of the Drug Utilization Research Group have been held at regular intervals in collaboration with the WHO Regional Office for Europe. These meetings aim at bringing together workers actively engaged in drug utilization research to discuss current projects, decide on common methodology and set priorities for future activities, The 1989 meeting of the WBO Drug Utilization Research Group was held in Noordwijkerhout, the Netherlands. From 5 to 7 June 86 participants, 19 observers and 6 staff members from WHO Headquarters and the Regional Office + for Europe were gathere,d to discuss various issues of drug utilization research. The International Narcotics Control Board was also represented. When the WHO Drug Utilization Research Group started, it was a mere European matter. In 1989 the attendants came from all over the world. The main objective of this meeting was to discuss the methodology of drug utilization research in various age groups, ranging from the unborn child to the elderly. Furthermore, overviews were presented of the facilities available for drug utilization research in various countries and a proposal fox national coordination of drug utilization research was drawn up.

Table of Contents
contents Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Opening of the meeting . . . . . . . . . . . . . . . . . . . 1 Overview of drug utilization research in the Netherlands and othercountries . . . . . . . . . . . . . . . . . . . . . . . . 3 3.1 Drug utilization research in the Netherlands. by F.M. Haaijer-Ruskamp . . . . . . . . . . . . . . . . . . 3 3.2 Drug utilization research in other countries. by K . Griffiths . 3.3 Discussion . . .. ..... .. ....... ....... ....... ....... .. 65 Reports from WHO Collaborating Centres . . . . . . . 6 4.1 Collaborating Centre for Drug Statistics Methodology. by K . ijydvin . . . . . . . . . . . . . . . . . . . . . . . 6 4.2 Collaborating Centre for Clinical Pharmacology. and Drug Policy Sciences. by F.M. Haaijer-Ruskamp . . . . . . . . . 7 4.3 UCsoel laofb oDrrautgi nUgt Cielinztartei ofno rM eItnhtoedrsn.a tbiyo aMn a.l L Dirnudgq uMiosnti to.ri.ng. .. . 8 4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . 9 WHOIEURO Copenhagen and WHOIHeadquarters Geneva . . . . . . . . 9 5.1 Appropriate technology for health and drug utilization research. by V . Thambypillai . . . . . . . . . . . . . . . 9 5.2 Utilization studies of psychoactive drugs. by I . Kahn . . . 10 Drug use in different age groups . . . . . . . . . . . . . . . . 11 6.1 Drug use in different age groups. by G . Tognoni . . . . . . 11 6.2 Discussion . . . . . . . . . . . . . . . . . . . . . . . . 12 Drug use in pregnancy and lactation . . . . . . . . . . . . . . 13 7.1 Drug use in pregnancy. by M . Bonati . . . . . . . . . . . . 13 7.2 Discussion . . . . . . . . . . . . . . . . . . . . . . 15 7.3 Drug use in lactation studies . Issues and pitfalls. byI.Matheson . . . . . . . . . . . . . . . . . . . . . . 16 Recoamvendations . . . . . . . . . . . . . . . . . . . . 18 Discussion of Ms Hatheson's paper . . . . . . . . . . . 18 7.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . 19